Quinton Ng, PhD, BPharm, is a postdoctoral researcher on the Yale Cancer Center Decision Science Team and Goshua Lab. A pharmacist by training and a pharmacoepidemiologist, he focuses on health outcomes research with a deep commitment to ensuring equitable care across the cancer care continuum. His passion for this work is profoundly personal, stemming from his experience as a caregiver.
His doctoral research at the University of California, Irvine, which earned him the PhRMA Foundation Predoctoral Fellowship, established a novel framework for incorporating integrative oncology therapies into cancer survivorship from an evidence-, science-, and value-based perspective.
At Yale, he continues his research by developing expertise at the intersection of pharmacoepidemiology and decision science. His current work focuses on quantifying the value of new therapies and underutilized interventions in clinical oncology and hematology to inform evidence-based practice, improve patient outcomes, enhance healthcare decision making, and optimize healthcare resource allocation.